Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the  Terms of Use and  Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA's XBRL website for information about XBRL and the voluntary program.
Click here for information about XBRL software and viewing XBRL financial statements.

Franklin World Health Sciences and Biotech Fund
Date of Formation:	Mar 16 2000	Auditor:	PricewaterhouseCoopers LLP
Sales Compensation:	Option of Sales Charge or Redemption Charge	(Principal) Custodian:	Royal Bank of Canada
Investment Fund Type:	Foreign Common Shares	(Principal) Distributor:	Franklin Templeton Investments Corp.
Eligible for RRSP:	No	Investment Portfolio Manager:	Franklin Advisers, Inc.
Financial Year-End:	Dec 31	Trustee:	Franklin Templeton Investments Corp.
Reporting Jurisdictions:	Ceased Reporting

Use of this site is subject to, and your continued use constitutes your express agreement to be
bound by, the  Terms of Use and  Privacy Statement.
Any unauthorized use of this site is strictly prohibited.

XBRL Voluntary Filing Program
Visit the CSA's XBRL website for information about XBRL and the voluntary program.
Click here for information about XBRL software and viewing XBRL financial statements.